JP3803392B2 - 環式付着阻害剤 - Google Patents

環式付着阻害剤 Download PDF

Info

Publication number
JP3803392B2
JP3803392B2 JP15346293A JP15346293A JP3803392B2 JP 3803392 B2 JP3803392 B2 JP 3803392B2 JP 15346293 A JP15346293 A JP 15346293A JP 15346293 A JP15346293 A JP 15346293A JP 3803392 B2 JP3803392 B2 JP 3803392B2
Authority
JP
Japan
Prior art keywords
gly
cyclic
phe
asp
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP15346293A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06293659A (ja
Inventor
ヨンチク アルフレート
ホヨルツマン ギュンター
フェルディンク−ハーバーマン ブルンヒルデ
メルツァー グイード
ディーフェンバッハ ベアーテ
アー． ヒェレシュ ダフィト
ケスラー ホルスト
グラート マリオン
ミュラー ゲルハルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JPH06293659A publication Critical patent/JPH06293659A/ja
Application granted granted Critical
Publication of JP3803392B2 publication Critical patent/JP3803392B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP15346293A 1992-07-06 1993-06-24 環式付着阻害剤 Expired - Lifetime JP3803392B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90936792A 1992-07-06 1992-07-06
US2202493A 1993-02-24 1993-02-24
US022/024 1993-02-24
US909/367 1993-02-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004137652A Division JP4192114B2 (ja) 1992-07-06 2004-05-06 環式付着阻害剤

Publications (2)

Publication Number Publication Date
JPH06293659A JPH06293659A (ja) 1994-10-21
JP3803392B2 true JP3803392B2 (ja) 2006-08-02

Family

ID=26695386

Family Applications (2)

Application Number Title Priority Date Filing Date
JP15346293A Expired - Lifetime JP3803392B2 (ja) 1992-07-06 1993-06-24 環式付着阻害剤
JP2004137652A Expired - Lifetime JP4192114B2 (ja) 1992-07-06 2004-05-06 環式付着阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004137652A Expired - Lifetime JP4192114B2 (ja) 1992-07-06 2004-05-06 環式付着阻害剤

Country Status (19)

Country Link
US (1) US5866540A (enExample)
EP (1) EP0578083B1 (enExample)
JP (2) JP3803392B2 (enExample)
KR (1) KR100261898B1 (enExample)
CN (1) CN1065438C (enExample)
AT (1) ATE178491T1 (enExample)
AU (2) AU675946B2 (enExample)
CA (1) CA2099541C (enExample)
CZ (1) CZ283744B6 (enExample)
DE (1) DE69324305T2 (enExample)
DK (1) DK0578083T3 (enExample)
ES (1) ES2131542T3 (enExample)
HU (1) HU212572B (enExample)
MX (1) MX9304035A (enExample)
NO (1) NO307985B1 (enExample)
PL (1) PL173785B1 (enExample)
SK (1) SK282024B6 (enExample)
TW (1) TW393319B (enExample)
UA (1) UA43823C2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654267A (en) * 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
DE4310643A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
US6056958A (en) * 1994-12-09 2000-05-02 Dupont Pharmaceuticals Method of treatment of arterial and venous thromboembolic disorders
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
DE4444260A1 (de) * 1994-12-13 1996-06-20 Hoechst Ag Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
US5780426A (en) * 1995-06-07 1998-07-14 Ixsys, Incorporated Fivemer cyclic peptide inhibitors of diseases involving αv β3
US5767071A (en) * 1995-06-07 1998-06-16 Ixsys Incorporated Sevenmer cyclic peptide inhibitors of diseases involving αv β3
US7053041B1 (en) * 1996-05-31 2006-05-30 The Scripps Research Institute Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
ATE308981T1 (de) * 1995-08-14 2005-11-15 Scripps Research Inst Verfahren und mittel zur hemmung der durch alpha v beta 5 vermittelten angiogenese
US5817750A (en) * 1995-08-28 1998-10-06 La Jolla Cancer Research Foundation Structural mimics of RGD-binding sites
US6080719A (en) * 1996-02-23 2000-06-27 Hoechst Aktiengesellschaft Cyclohexapeptides and their mixtures, a process for preparing them, and their use
DE19613933A1 (de) * 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
SK163598A3 (en) 1996-05-31 1999-06-11 Scripps Research Inst Methods and compositions useful for inhibition of angiogenesis
US6245809B1 (en) 1996-12-09 2001-06-12 Cor Therapeutics Inc. Integrin antagonists
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide
DE19736772A1 (de) * 1997-08-23 1999-02-25 Merck Patent Gmbh Cyclopeptidderivate
US6852318B1 (en) * 1998-05-08 2005-02-08 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
WO1999065944A1 (en) * 1998-06-15 1999-12-23 Ixsys Incorporated PEPTIDE INHIBITORS OF αVβ3 AND αVβ¿5?
AU756916B2 (en) * 1998-11-12 2003-01-23 Jcr Pharmaceuticals Co., Ltd. Modulation of cell proliferative disorders by cyclic RGD
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
CA2405469C (en) 2000-04-12 2012-03-20 Amersham Health As Integrin binding peptide derivatives
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
US20030082103A1 (en) * 2000-10-11 2003-05-01 Targesome, Inc. Targeted therapeutic lipid constructs having cell surface targets
US20040029788A1 (en) * 2000-11-01 2004-02-12 Hans-Markus Bender Methods and compositions for the treatment of diseases of the eye
ATE415163T1 (de) 2000-11-01 2008-12-15 Merck Patent Gmbh Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
BRPI0210886B8 (pt) 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
RU2214416C2 (ru) * 2001-12-10 2003-10-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Rgd-содержащие пептиды
US7597907B2 (en) * 2004-11-05 2009-10-06 Trustees Of The University Of Pennsylvania Antioxidant polymer nanocarriers for use in preventing oxidative injury
US7605056B2 (en) 2005-05-31 2009-10-20 Semiconductor Energy Laboratory Co., Ltd. Method of manufacturing a semiconductor device including separation by physical force
US8568786B2 (en) * 2007-10-27 2013-10-29 The Trustees Of The Universtiy Of Pennsylvania Method and compositions for polymer nanocarriers containing therapeutic molecules
US7927629B2 (en) * 2007-10-27 2011-04-19 The Trustees Of The University Of Pennsylvania Method and compositions for polymer nanocarriers containing therapeutic molecules
CN101990425B (zh) * 2008-04-08 2016-01-20 默克专利股份有限公司 包含环肽的组合物和使用方法
US20110256055A1 (en) 2008-12-23 2011-10-20 Ge Healthcare Limited Application of 99mtc peptide-based compound as a bone marrow imaging agent
CN103153328A (zh) * 2010-07-16 2013-06-12 默克专利股份有限公司 肽在乳腺癌和/或骨转移灶的治疗中的用途
DK2892540T3 (en) * 2012-09-06 2018-11-19 Mcpharma Biotech Inc TREATMENT OF DIARRES AND DRAWN DIARRES WITH RESISTANT POTATO STARCH
US11001609B2 (en) 2017-04-24 2021-05-11 The Regents Of The University Of California Cell permeable cyclic peptide scaffolds
WO2019058374A1 (en) * 2017-09-19 2019-03-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. N-METHYLATED CYCLIC PEPTIDES AND PRODRUGS THEREOF
KR102213196B1 (ko) * 2018-05-08 2021-02-05 주식회사 메디폴리머 클릭화학 반응을 통해 필러 또는 약물전달체로 사용하기 위한 주사제형 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
EP0410537A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
DK0527798T3 (da) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds

Also Published As

Publication number Publication date
SK70693A3 (en) 1994-02-02
SK282024B6 (sk) 2001-10-08
NO932439D0 (no) 1993-07-05
AU4179693A (en) 1994-01-13
EP0578083A2 (en) 1994-01-12
JPH06293659A (ja) 1994-10-21
US5866540A (en) 1999-02-02
NO307985B1 (no) 2000-07-03
HUT66348A (en) 1994-11-28
NO932439L (no) 1994-01-07
DK0578083T3 (da) 1999-10-18
AU675946B2 (en) 1997-02-27
ATE178491T1 (de) 1999-04-15
ES2131542T3 (es) 1999-08-01
KR100261898B1 (ko) 2000-07-15
UA43823C2 (uk) 2002-01-15
CZ283744B6 (cs) 1998-06-17
JP2004224803A (ja) 2004-08-12
DE69324305T2 (de) 1999-11-04
CN1065438C (zh) 2001-05-09
AU1268797A (en) 1997-03-20
CA2099541A1 (en) 1994-01-07
MX9304035A (es) 1994-04-29
PL299559A1 (en) 1994-03-21
DE69324305D1 (de) 1999-05-12
CN1084408A (zh) 1994-03-30
HU212572B (en) 1996-08-29
EP0578083A3 (enExample) 1994-08-03
CZ131593A3 (en) 1994-02-16
HU9301950D0 (en) 1993-09-28
TW393319B (en) 2000-06-11
PL173785B1 (pl) 1998-04-30
CA2099541C (en) 2009-08-25
JP4192114B2 (ja) 2008-12-03
EP0578083B1 (en) 1999-04-07
KR940001900A (ko) 1994-02-16

Similar Documents

Publication Publication Date Title
JP3803392B2 (ja) 環式付着阻害剤
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
US4997651A (en) Pharmaceutical formulations
JPH05505808A (ja) 創傷の治癒を促進するためへの銅（２）含有化合物の使用
CN108084246A (zh) 多肽和多肽相关化合物的高穿透力前药组合物
US5538951A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions
CN105764487A (zh) Amg 416（velcalcetide）的稳定的液体制剂
EP1309613B1 (en) Pharmaceutical composition comprising an analgesic peptide
RU2116081C1 (ru) Циклические ингибиторы адгезии
AU665789B2 (en) Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
JPH0665290A (ja) 線状ペプチド
JPH03120225A (ja) 新規ペプチドおよびこれを含有する降圧剤
KR0133998B1 (ko) 위장질환 치료용 의약 조성물
US6136788A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions
US5814611A (en) Pharmaceutical for the therapy of immune deficiency conditions
JPH03120224A (ja) 新規ペプチドおよびこれを含有する降圧剤
HK1168602A (en) High penetration prodrug compositions of peptides and peptide-related compounds
EP0621789A1 (en) Pharmaceutical pentapeptide compositions and methods of use thereof
JP2006516980A (ja) 骨関節症の治療へのブラジキニン−ｂ２受容体拮抗薬の使用
JPH0548238B2 (enExample)
JPH03197493A (ja) 新規ペプチド
PH26521A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040205

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040506

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060508

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100512

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110512

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110512

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120512

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130512

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130512

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term